Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2

Mayes, CM; Santarpia, JL

Mayes, CM (通讯作者),Sandia Natl Labs, WMD Threats & Aerosol Sci, 1515 Eubank Blvd SE, Albuquerque, NM 87123 USA.

CRISPR JOURNAL, 2023; 6 (4): 359

Abstract

CRISPR-based technology has become widely used as an antiviral strategy, including as a broad-spectrum human coronavirus (HCoV) therapeutic. In this w......

Full Text Link